Warning letter
Ultracell Medical Technologies: warning letter of Feb 3, 2003
FDA warning letter UCM147291 · New England District Office
Key facts
| Reference number | UCM147291 |
|---|---|
| Company | Ultracell Medical Technologies |
| Subject | Quality System Regulation/Good Manufacturing Practice for Medical Devices/Adulterated |
| Issue date | Feb 3, 2003 |
| Posted date | Feb 3, 2003 |
| Issuing office | New England District Office |
| Product type | Devices |
| CFR sections cited | 820 |
| Country | 3 |
| Inspection city | Caledonia |
| Inspection ZIP | 49316-7664 |
| Inspection start date | Dec 31, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: